Thretide[18F]

氟[18F]思睿肽

Report date: 2026/05/20 20:02:01

NME

Base Information

Drug NameThretide[18F]

Drug Alias Name[18F] ThretideSpiritide[18F]Al18F-PSMA-BCH18F-Thretide PET/CTAl18F-PSMA-BCH PET/CT +[7]

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionPositron-emission tomography enhancersProstate-Specific Membrane Antigen inhibitors

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsDiagnostic agentsProstatic NeoplasmsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusNDA/BLA

Highest Status in ChinaNDA/BLA

Originator CompaniesYantai Lannacheng Biotechnology Co Ltd

China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesYantai Lannacheng Biotechnology Co Ltd

Inactive CompaniesTumor Research Institute Chinese Academy Of Medical Sciences

Active IndicationsDiagnostic agentsProstatic Neoplasms

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A